More and more studies have started to show that aspirin improves the outlook of cancer treatment by 20-30%. Peter Elwood, from the University of Cardiff, said that “The use of low-dose aspirin as a preventive in heart disease, stroke, and cancer is well established, but evidence is now emerging that the drug may have a valuable role as an additional treatment for cancer, too.” After his research, his analysis revealed that ‘the chances of surviving a cancer diagnosis were 20–30 percent greater among people who took aspirin compared with those who did not. This was true at any given point after receiving the diagnosis.’ There was also evidence to show that aspirin can reduce the risk of dying from colon cancer by 25%, the risk of dying from breast cancer by 20%, and the risk of dying from prostate cancer by 15%.
Another point Elwood wanted to emphasise was the importance of allowing patients to access evidence – if patients know the evidence from recent studies they are more likely to make more informed and beneficial decisions about new treatment options.
Thank you for reading this weeks blog. It has been quite some time since I wrote my last blog, but I’m back from taking a break and I will start to write my blogs weekly / fortnightly again.